Bringing the fundamentals into focus…
Back to TG Therapeutics, Inc.
How TG Therapeutics, Inc. stacks up
TGTX · against 171 other Healthcare companies of similar size
Overall
64/ 100
Above the middle of the pack.
Ranked #47 of 172 · scores higher than 68% of peers
Bars: peers in each 10-point band of the overall score45 peers with an overall score of 60–69, including TGTX · Click a bar to see the companies
The four scores behind it
Overall = average of valuation, growth, profitability and safety percentile (categories without data are skipped)Ranking by overall score
Top 5 and the companies ranked around TGTX| Rank | Company | Market cap | Overall | Valuation | Growth | Profitability | Risk |
|---|---|---|---|---|---|---|---|
| 1 | 37.3B HKD (≈$4.8B) | 90 | 99 | 98 | 84 | 0 / 2 | |
| 2 | 921.9B INR (≈$11.1B) | 82 | 84 | 80 | 94 | 0 / 2 | |
| 3 | 936.1B JPY (≈$6.4B) | 80 | 65 | 86 | 94 | 0 / 2 | |
| 4 | 10.7B USD | 78 | 77 | 85 | 84 | 0 / 2 | |
| 4 | 9.0B USD | 78 | 50 | 80 | 94 | 0 / 2 | |
| 47 | 5.8B USD | 64 | 93 | 79 | 69 | 2 / 2 | |
| 47 | 3.6B GBP (≈$4.7B) | 64 | 93 | 53 | 84 | 2 / 2 | |
| 47 | 10.0B USD | 64 | 90 | 92 | 56 | 2 / 2 | |
| 47 | 11.4B USD | 64 | 46 | 74 | 82 | 1 / 2 | |
| 47 | 9.3B USD | 64 | 55 | 98 | 87 | 2 / 2 | |
| 47 | 10.4B USD | 64 | 96 | 60 | 79 | 2 / 2 | |
| 56 | 692.7B JPY (≈$4.7B) | 63 | 94 | 43 | 52 | / 2 | |
| 56 | 11.2B EUR (≈$12.3B) | 63 | 79 | 37 | 78 | 1 / 2 | |
| 56 | 7.0B USD | 63 | 47 | 77 | 80 | 1 / 2 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score